Akari Murata

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Efficacy and safety of pleurodesis for lung cancer patients with interstitial lung disease.

Efficacy and safety of pleurodesis for lung cancer patients with interstitial lung disease.

Journal: Journal of thoracic disease

Published: September 18, 2024

The Histopathology of Abemaciclib-Induced Interstitial Lung Disease: A First Case Report With Transbronchial Lung Cryobiopsy.

The Histopathology of Abemaciclib-Induced Interstitial Lung Disease: A First Case Report With Transbronchial Lung Cryobiopsy.

Journal: Breast cancer : basic and clinical research

Published: July 05, 2024

Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report.

Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report.

Journal: OncoTargets and therapy

Published: January 12, 2023

Bronchial Cast Hiding Pulmonary Tuberculosis.

Bronchial Cast Hiding Pulmonary Tuberculosis.

Journal: American journal of respiratory and critical care medicine

Published: December 03, 2021

Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung disease.

Kinetic changes in serum KL-6 levels predict disease progression in patients with systemic sclerosis-associated interstitial lung disease.

Journal: Respiratory medicine

Published: September 04, 2021

Late-onset programmed cell death protein-1 inhibitor-induced pneumonitis after cessation of nivolumab or pembrolizumab in patients with advanced non-small cell lung cancer: a case series.

Late-onset programmed cell death protein-1 inhibitor-induced pneumonitis after cessation of nivolumab or pembrolizumab in patients with advanced non-small cell lung cancer: a case series.

Journal: Translational lung cancer research

Published: April 23, 2021

Fractional analysis of bronchoalveolar lavage in systemic sclerosis-associated interstitial lung disease.

Fractional analysis of bronchoalveolar lavage in systemic sclerosis-associated interstitial lung disease.

Journal: Journal of thoracic disease

Published: August 04, 2020

Remission of psoriasis with nintedanib for the treatment of idiopathic pulmonary fibrosis.

Remission of psoriasis with nintedanib for the treatment of idiopathic pulmonary fibrosis.

Journal: The Journal of dermatology

Published: September 12, 2018

Lung cancer in connective tissue disease-associated interstitial lung disease: clinical features and impact on outcomes.

Lung cancer in connective tissue disease-associated interstitial lung disease: clinical features and impact on outcomes.

Journal: Journal of thoracic disease

Published: April 03, 2018

Successful treatment of non-tuberculous mycobacterial pleurisy with acute fever by antimycobacterial therapy.

Successful treatment of non-tuberculous mycobacterial pleurisy with acute fever by antimycobacterial therapy.

Journal: BMJ case reports

Published: February 14, 2018

Long-lasting shrinkage in tumor mass after discontinuation of nivolumab treatment.

Long-lasting shrinkage in tumor mass after discontinuation of nivolumab treatment.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: February 17, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026